1. Kawabata, Hiroshi. 2018. Transferrin and transferrin receptors update. In Free radical biology & medicine, 133, 46-54. doi:10.1016/j.freeradbiomed.2018.06.037. https://pubmed.ncbi.nlm.nih.gov/29969719/
2. Pietrangelo, Antonello. 2010. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. In Gastroenterology, 139, 393-408, 408.e1-2. doi:10.1053/j.gastro.2010.06.013. https://pubmed.ncbi.nlm.nih.gov/20542038/
3. Chen, Haitao, Luo, Jun, Guo, Jianchun. 2020. Development and validation of a five-immune gene prognostic risk model in colon cancer. In BMC cancer, 20, 395. doi:10.1186/s12885-020-06799-0. https://pubmed.ncbi.nlm.nih.gov/32375704/
4. Alvarenga, Aline Morgan, Brissot, Pierre, Santos, Paulo Caleb Junior Lima. . Haemochromatosis revisited. In World journal of hepatology, 14, 1931-1939. doi:10.4254/wjh.v14.i11.1931. https://pubmed.ncbi.nlm.nih.gov/36483608/
5. Silvestri, Laura, Nai, Antonella, Pagani, Alessia, Camaschella, Clara. 2014. The extrahepatic role of TFR2 in iron homeostasis. In Frontiers in pharmacology, 5, 93. doi:10.3389/fphar.2014.00093. https://pubmed.ncbi.nlm.nih.gov/24847265/
6. Powell, Lawrie W, Seckington, Rebecca C, Deugnier, Yves. 2016. Haemochromatosis. In Lancet (London, England), 388, 706-16. doi:10.1016/S0140-6736(15)01315-X. https://pubmed.ncbi.nlm.nih.gov/26975792/
7. Yang, Yan, Du, Jie, Huang, Yun-Fei, Li, Dan, Chen, Rui. 2023. Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer. In Oncology letters, 27, 43. doi:10.3892/ol.2023.14176. https://pubmed.ncbi.nlm.nih.gov/38106522/